Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-DONEPEZIL | 10MG | TABLET | Resolved | 2022-03-04 | 2022-03-09 | 156033 |
APO-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-03-04 | 2022-03-24 | 156036 |
APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-04 | 2022-05-09 | 156039 |
APO-ONDANSETRON | 4MG | SOLUTION | Resolved | 2022-03-07 | 2022-07-15 | 156214 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2022-03-09 | 2022-06-17 | 156387 |
APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2022-03-11 | 2022-03-11 | 156534 |
APO-COLESEVELAM | 625MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156537 |
APO-MELOXICAM | 1.5G | SUSPENSION | Resolved | 2022-03-11 | 2022-05-05 | 156540 |
APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156543 |
APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156546 |
APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156549 |
APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-03-11 | 2022-03-25 | 156552 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2022-03-11 | 2022-04-01 | 156555 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2022-03-15 | 2022-05-20 | 156758 |
APO-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Resolved | 2022-03-15 | 2022-05-19 | 156762 |
APO-TELMISARTAN-AMLODIPINE | 10MG 80MG | TABLET | Actual shortage | 2022-03-16 | 2022-09-14 | 156794 |
ANAFRANIL | 25MG | TABLET | Resolved | 2022-03-18 | 2022-04-04 | 156980 |
APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-01 | 156983 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-18 | 2022-04-06 | 156987 |
APO-DIVALPROEX | 500MG | TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) | Resolved | 2022-03-18 | 2022-09-30 | 156990 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
APO-OLANZAPINE | 5.0MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4968 |
APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-DOCUSATE SODIUM | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2019-03-29 | 40733 |
DOCUSATE SODIUM CAPSULES | 100MG | CAPSULE | Discontinued | 2018-02-23 | 2018-09-15 | 40738 |
APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |